The very signaling pathways now recognized as being cholesterol-dependent: AR, TGFβ, EGF, MAPK/ERK, AP-1, and AKT, are well characterized as prostate cancer relevant [62, 63]. This evidence concerns the gene EGF and prostate carcinoma.